North American Graves’ disease market is growing at a CAGR of around 4.3% during the forecast period. North American Grave’s disease market has been primarily driven by increasing prevalence of thyroid disorders, and significant awareness about thyroid treatment and diagnosis. Moreover, some initiatives to support Americans suffering from thyroid disease are also contributing to the growth of the North American Graves’ disease market. For instance, in January 2016, AmeriCares supported thousands of Americans suffering from thyroid disease in terms of providing medication. This donation was conducted in recognition of Thyroid Awareness Month. This will enable health and emergency response organizations to offer levothyroxine therapy for an average 25,000 underinsured, insured, and low-income patients of community health centers and clinics nationwide.

Visit for Global Graves Disease Market Report at: https://www.omrglobal.com/industry-reports/graves-disease-market

According to the American Thyroid Association, approximately 20 million people all over the US have some kind of thyroid disorders. Several patients require medication to control the functioning of the thyroid and needs treatment for life. Akrimax Pharmaceuticals, LLC, located in Cranford, New Jersey, US is a key sponsor of the thyroid month campaign. The company donated $2.4 million worth of levothyroxine therapy. This is sufficient to meet monthly prescriptions for approximately 25,000 patients. 

Due to significant rise in the prevalence of thyroid disorders, the increasing number of smokers, the considerable population suffering from type-1 diabetes and launching of thyroid awareness programs by pharmaceutical companies in North America. The North American Graves’ disease market has been estimated to grow at a CAGR of 4.3% during the forecast period of 2018-2023. The US is the leading shareholder in the North American Grave’s diseases market. Substantial funding for R&D activities in the US is also contributing towards the North American Graves’ disease during the forecast period.

Research Methodology

The market study of the North American Graves’ disease market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. North American Graves’ Disease Market Research and Analysis by Diagnosis
2. North American Graves’ Disease Market Research and Analysis by Treatment

The Report Covers

• Comprehensive research methodology of the North American Graves’ disease market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the North American Graves’ disease market.
• Insights about market determinants which are stimulating the North American Graves’ disease market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.